• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

实验动物临床体征报告:FELASA工作组报告

The reporting of clinical signs in laboratory animals: FELASA Working Group Report.

作者信息

Fentener van Vlissingen J M, Borrens M, Girod A, Lelovas P, Morrison F, Torres Y Saavedra

机构信息

NVP (Nederlandse Vereniging voor Proefdierkunde), Erasmus Laboratory Animal Science Center EDC, Erasmus MC, Rotterdam, The Netherlands

BCLAS (Belgian Council for Laboratory Animal Science), Rommel Consulting Partners, Lab Animal Sciences and Medicine, Jodoigne, Belgium.

出版信息

Lab Anim. 2015 Oct;49(4):267-83. doi: 10.1177/0023677215584249. Epub 2015 May 8.

DOI:10.1177/0023677215584249
PMID:25957286
Abstract

Observing and reporting clinical signs in laboratory animals is necessary for many reasons: the assessment of animal welfare, compliance with the principle of refinement (e.g. humane endpoints), regulatory compliance (e.g. reporting severity) and, importantly, as a scientific outcome, e.g. in animal models of disease or safety studies. Developments in the reporting of clinical signs will enhance the scientific value gained from animal experiments and further address the ethical cost. This paper discusses systematic approaches to the observation and reporting of clinical signs in animals (to be) used for research. Glossaries from public and corporate institutions have been consulted and a reference glossary has been set up, providing terminology to be tailored for institutional or project-specific use. The clinical examination of animals must be carried out by competent and specifically trained staff in a systematic way and repeated at adequate intervals and clinical observations must be registered effectively to allow this information to be used. The development of institutional or project-specific glossaries and the use of handwritten records or automated databases are discussed in detail. Among the users are animal care staff, veterinarians and researchers who will need to agree on a given set of clinical signs to be monitored routinely or as a scientific read-out and to train for the proper application. The paper introduces a long list of clinical signs with scientific terminology, descriptions and explanations as a reference glossary to be published and maintained online as a living document supported by the authors as an editorial committee.

摘要

出于多种原因,观察和报告实验动物的临床体征很有必要:评估动物福利、符合优化原则(如人道终点)、符合监管要求(如报告严重程度),以及重要的是,作为一种科学成果,例如在疾病动物模型或安全性研究中。临床体征报告方面的进展将提高动物实验的科学价值,并进一步解决伦理成本问题。本文讨论了用于研究的动物临床体征观察和报告的系统方法。已参考了公共机构和企业机构的术语表,并建立了一个参考术语表,提供可根据机构或项目具体情况进行调整的术语。动物的临床检查必须由有能力且经过专门培训的人员以系统的方式进行,并在适当的间隔重复进行,临床观察结果必须有效记录,以便使用这些信息。本文详细讨论了机构或项目特定术语表的制定以及手写记录或自动化数据库的使用。使用者包括动物护理人员、兽医和研究人员,他们需要就一组常规监测的或作为科学读数的临床体征达成一致,并进行正确应用的培训。本文介绍了一长串带有科学术语、描述和解释的临床体征,作为一个参考术语表,将作为一份动态文件在线发布并由作为编辑委员会的作者维护。

相似文献

1
The reporting of clinical signs in laboratory animals: FELASA Working Group Report.实验动物临床体征报告:FELASA工作组报告
Lab Anim. 2015 Oct;49(4):267-83. doi: 10.1177/0023677215584249. Epub 2015 May 8.
2
Guidelines for the Care and Welfare of Cephalopods in Research -A consensus based on an initiative by CephRes, FELASA and the Boyd Group.研究中头足类动物的护理与福利指南——基于CephRes、FELASA和博伊德集团倡议达成的共识。
Lab Anim. 2015 Jul;49(2 Suppl):1-90. doi: 10.1177/0023677215580006.
3
A guide to defining and implementing protocols for the welfare assessment of laboratory animals: eleventh report of the BVAAWF/FRAME/RSPCA/UFAW Joint Working Group on Refinement.实验室动物福利评估方案的制定和实施指南:英国兽医行为学会/动物福利基金会/皇家防止虐待动物协会/联合动物福利学会改良工作组第十一次报告。
Lab Anim. 2011 Jan;45(1):1-13. doi: 10.1258/la.2010.010031. Epub 2010 Dec 1.
4
Guidelines for the veterinary care of laboratory animals: report of the FELASA/ECLAM/ESLAV Joint Working Group on Veterinary Care.实验动物的兽医护理指南:FELASA/ECLAM/ESLAV兽医护理联合工作组报告
Lab Anim. 2008 Jan;42(1):1-11. doi: 10.1258/la.2007.007027.
5
Housing and care of laboratory cats: from requirements to practice.实验猫的饲养与照料:从要求到实践
Schweiz Arch Tierheilkd. 2011 Apr;153(4):157-64. doi: 10.1024/0036-7281/a000175.
6
Surrogate Humane Endpoints in Small Animal Models of Acute Lung Injury: A Modified Delphi Consensus Study of Researchers and Laboratory Animal Veterinarians.小动物急性肺损伤模型中的替代人道终点:研究人员和实验动物兽医的改良 Delphi 共识研究。
Crit Care Med. 2021 Feb 1;49(2):311-323. doi: 10.1097/CCM.0000000000004734.
7
[The use of transgenic animals in biomedical research in Germany. Part 2: Ethical evaluation of the use of transgenic animals in biomedical research and perspectives for the changeover in research to research animal-free methods].[德国生物医学研究中转基因动物的应用。第2部分:生物医学研究中转基因动物应用的伦理评估及向无动物研究方法转变的前景]
ALTEX. 2006;23(1):3-16.
8
Report of the FELASA Working Group on evaluation of quality systems for animal units.实验动物设施质量体系评估FELASA工作组报告。
Lab Anim. 2004 Apr;38(2):103-18. doi: 10.1258/002367704322968786.
9
Endpoint matrix: a conceptual tool to promote consideration of the multiple dimensions of humane endpoints.终点矩阵:一个促进考虑人道终点多维度的概念工具。
ALTEX. 2014;31(2):209-13. doi: 10.14573/altex.1307261.
10
Advancing refinement of laboratory animal use.推进实验动物使用的精细化。
Lab Anim. 1998 Apr;32(2):137-42. doi: 10.1258/002367798780600016.

引用本文的文献

1
Peptide-mimetics derived from leucyl-tRNA synthetase are potential agents for the therapy of mt-tRNA related diseases.源自亮氨酰 - tRNA合成酶的肽模拟物是治疗线粒体tRNA相关疾病的潜在药物。
Front Pharmacol. 2025 Jul 28;16:1607343. doi: 10.3389/fphar.2025.1607343. eCollection 2025.
2
Best Practices in the Development and Use of Experimental Models of Bacterial Pneumonia: An Official American Thoracic Society Workshop Report.细菌性肺炎实验模型开发与应用的最佳实践:美国胸科学会官方研讨会报告
Am J Respir Cell Mol Biol. 2025 Aug;73(2):178-199. doi: 10.1165/rcmb.2025-0322ST.
3
Impact of irradiation conditions on therapy of Lewis lung carcinoma in mice using glucose-ethylenediamine carbon dots.
辐照条件对使用葡萄糖-乙二胺碳点治疗小鼠Lewis肺癌的影响。
BMC Cancer. 2025 Jan 8;25(1):39. doi: 10.1186/s12885-024-13404-1.
4
Dual-targeting CRISPR-CasRx reduces C9orf72 ALS/FTD sense and antisense repeat RNAs in vitro and in vivo.双靶点CRISPR-CasRx在体外和体内均可减少C9orf72肌萎缩侧索硬化症/额颞叶痴呆的正义和反义重复RNA。
Nat Commun. 2025 Jan 8;16(1):459. doi: 10.1038/s41467-024-55550-x.
5
Unwanted disorders and xenogeneic graft-versus-host disease in experimental immunodeficient mice: How to evaluate and how to report.实验性免疫缺陷小鼠中的不良病症及异种移植物抗宿主病:如何评估及如何报告。
Animal Model Exp Med. 2025 Jan;8(1):20-29. doi: 10.1002/ame2.12509. Epub 2024 Nov 27.
6
C Fullerene Reduces the Level of Liver Damage in Chronic Alcohol Intoxication of Rats.富勒烯 C 可降低慢性酒精中毒大鼠的肝损伤水平。
Molecules. 2024 Jun 21;29(13):2951. doi: 10.3390/molecules29132951.
7
Humane Endpoint: Example from a Murine Model of Disseminated Sporotrichosis.人道终点:播散性孢子丝菌病的鼠模型实例。
Curr Microbiol. 2024 May 16;81(7):175. doi: 10.1007/s00284-024-03692-y.
8
Artificial intelligence generated clinical score sheets: looking at the two faces of Janus.人工智能生成的临床评分表:审视双面雅努斯
Lab Anim Res. 2024 May 16;40(1):21. doi: 10.1186/s42826-024-00206-6.
9
Enhancing radioprotection: A chitosan-based chelating polymer is a versatile radioprotective agent for prophylactic and therapeutic interventions against radionuclide contamination.增强辐射防护:基于壳聚糖的螯合聚合物是一种多功能的辐射防护剂,可用于放射性核素污染的预防和治疗干预。
PLoS One. 2024 Apr 3;19(4):e0292414. doi: 10.1371/journal.pone.0292414. eCollection 2024.
10
Immunogenicity and Pre-Clinical Efficacy of an OMV-Based SARS-CoV-2 Vaccine.基于外膜囊泡的新型冠状病毒2疫苗的免疫原性及临床前疗效
Vaccines (Basel). 2023 Sep 29;11(10):1546. doi: 10.3390/vaccines11101546.